AFP Promoter Enhancer Increased Specific Expression of the Human Sodium Iodide Symporter (hNIS) for Targeted Radioiodine Therapy of Hepatocellular Carcinoma

REFERENCES

• Levin B., Amos C. Therapy of unresectable hepatocellular carcinoma. N Engl J Med 1995; 332(19)1294–1296
   PubMed Web of Science ®Google Scholar
• el-Serag H. B. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2001; 5(1)87–107
   PubMedGoogle Scholar
• Chan D. W., Kelsten M., Rock R., Bruzek D. Evaluation of a monoclonal immunoenzymometric assay for alpha-fetoprotein. Clin Chem 1986; 32(7)1318–1322
   PubMed Web of Science ®Google Scholar
• Johnson P. J. Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma. J Gastroenterol Hepatol 1999; 14(Suppl.)32–36
   PubMedGoogle Scholar
• Watanabe K., Saito A., Tamaoki T. Cell-specific enhancer activity in a far upstream region of the human alpha-fetoprotein gene. J Bio1 Chem 1987; 262(10)4812–4818
   PubMed Web of Science ®Google Scholar
• Ido A., Nakata K., Kato Y., Nakao K., Murata K., Fujita M., Ishii N., Tamaoki T., Shiku H., Nagataki S. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of the human α -fetoprotein gene promoter. Cancer Res 1995; 55(14)3105–3109
   PubMed Web of Science ®Google Scholar
• Nettelbeck D. M., Jérôme V., Müller R. A strategy for enhancing the transcriptional activity of weak cell type-specific promoters. Gene Ther 1998; 5(12)1656–1664
   PubMed Web of Science ®Google Scholar
• Takikawa H., Mafune K., Hamada H., Nettelbeck D. M., Müller R., Makuuchi M., Kaminishi M. An advanced strategy of enhanced specific gene expression for hepatocellular carcinoma. Int J Oncol 2003; 22(5)1051–1056
   PubMed Web of Science ®Google Scholar
• Ido A., Uto H., Moriuchi A., Nagata K., Onaga Y., Onaga M., Hori T., Hirono S., Hayashi K., Tamaoki T. Tsubouchi, H. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human a-fetoprotein promoter. Cancer Res 2001; 61(7)3016–3021
   PubMed Web of Science ®Google Scholar
• Byeong-Cheol A., Min Jeong R., Sohn Joo A., Sun Mi Y., Seung Hee C., Jeongsoo Y., In-Kyu L., Jae-Tae L., Kyu-Bo L. Construction of a highly hepatoma specific adenoviral vector system carrying NIS gene activated by AFP enhancer. J Nucl Med 2006; 47(Suppl. 1)409P
   Google Scholar
• Vieja A. D.L., Dohan O., Levy O., Carrasco N. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol Rev 2000; 80(3)1083–1105
   PubMed Web of Science ®Google Scholar
• Dai G., Levy O., Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996; 379(6564)458–460
   PubMed Web of Science ®Google Scholar
• Dohán O., De la Vieja A., Paroder V., Riedel C., Artani M., Reed M., Ginter C. S., Carrasco N. The Sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 2003; 24(1)48–77, [PMID: 12588808]
   PubMed Web of Science ®Google Scholar
• Spitzweg C., Harrington K. J., Pinke L. A., Vile R. G., Morris J. C. The sodium/iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab 2001; 86(7)3327–3335
   PubMed Web of Science ®Google Scholar
• Mandell R. B., Mandell L. Z., Link C. J., Jr. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res 1999; 59(3)661–668
   PubMed Web of Science ®Google Scholar
• Boland A., Ricard M., Opolon P., Bidart J. M., Yeh P., Filetti S., Schlumberger M., Perricaudet M. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res 2000; 60(13)3484–3492
   PubMed Web of Science ®Google Scholar
• Nakamoto Y., Saga T., Misaki T., Kobayashi H., Sato N., Ishimori T., Kosugi S., Sakahara H., Konishi J. Establishment and characterization of a breast cancer cell line expressing Na/I symporters for radioiodide concentrator gene therapy. J Nucl Med 2000; 41(11)1898–1904
   PubMed Web of Science ®Google Scholar
• Haberkorn U., Henze M., Altmann A., Jiang S., Morr I., Mahmut M., Peschke P., Kübler W., Debus J., Eisenhut M. Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells. J Nucl Med 2001; 42(2)317–325
   PubMed Web of Science ®Google Scholar
• Schipper M. L., Weber A., Béhé M., Göke R., Joba W., Schmidt H., Bert T., Simon B., Arnold R., Heufelder A. E., Behr T. M. Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells. Cancer Res 2003; 63(6)1333–1338
   PubMed Web of Science ®Google Scholar
• Kakinuma H., Bergert E. R., Spitzweg C., Cheville J. C., Lieber M. M., Morris J. C. Probasin promoter (ARR2PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer. Cancer Res 2003; 63(22)7840–7844
   PubMed Web of Science ®Google Scholar
• Huang R., Kuang A., Yu H., Ma C., Tang G. Construction of the recombinant adenovirus carrying sodium/iodide symporter gene. J Biomed Eng 2005; 22(4)765–768
   Google Scholar
• Ueki T., Nakata K., Mawatari F., Tsuruta S., Ido A., Ishikawa H., Nakao K., Kato Y., Ishii N., Eguchi K. Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice. Int J Mol Med 1998; 1(4)671–675
   PubMed Web of Science ®Google Scholar
• Uto H., Ido A., Hori T., Hirono S., Hayashi K., Tamaoki T., Tsubouchi H. Hepatoma-specific gene therapy through retrovirus- mediated and targeted gene transfer using an adenovirus carrying the ecotropic receptor gene. Biochem Biophys Res Commun 1999; 265(2)550–555
   PubMed Web of Science ®Google Scholar
• Nakabayashi H., Watanabe K., Saito A., Otsuru A., Sawadaishi K., Tamaoki T. Transcriptional regulation of α -fetoprotein expression by dexamethasone in human hepatoma cells. J Biol Chem 1989; 264(1)266–271
   PubMed Web of Science ®Google Scholar
• Nakabayashi H., Hashimoto T., Miyao Y., Tjong K. K., Chan J., Tamaoki T. A position-dependent silencer plays a major role in repressing α -fetoprotein expression in human hepatoma. Mol Cell Biol 1991; 11(12)5885–5893
   PubMed Web of Science ®Google Scholar
• Mawatari F., Tsuruta S., Ido A., Ueki T., Nakao K., Kato Y., Tamaoki T., Ishii N., Nakata K. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human α -fetoprotein enhancer directly linked to its promoter. Cancer Gene Ther 1998; 5(5)301–306
   PubMed Web of Science ®Google Scholar
• Ishikawa H., Nakata K., Mawatari F., Ueki T., Tsuruta S., Ido A., Nakao K., Kato Y., Ishii N., Eguchi K. Utilization of variant-type of human α -fetoprotein promoter in gene therapy targeting for the hepatocellular carcinoma. Gene Ther 1999; 6(4)465–470
   PubMed Web of Science ®Google Scholar
• Cao G., Kuriyama S., Tsujinoue H., Chen Q. L. Akira Mrroro, ZH Qi. A novel approach for inducing enhanced and selective transgene expression in hepatocellular carcinoma cells. Int J Cancer 2000; 87(2)247–252
   Google Scholar
• Cao G., Kuriyama S., Gao J., Nakatani T., Chen Q., Yoshiji H., Zhao L., Kojima H., Dong Y., Fukui H., Hou J. Gene therapy for hepatocellular carcinoma based on tumor-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter. Eur J Cancer 2001; 37(1)140–147
   PubMed Web of Science ®Google Scholar
• Spitzweg C., Zhang S., Bergert E. R., Castro M. R., McIver B., Heufelder A. E., Tindall D. J., Young C. Y., Morris J. C. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Cancer Res 1999; 59(9)2136–2141
   PubMed Web of Science ®Google Scholar
• Kang J. H., Chung J. K., Lee Y. J., Shin J. H., Jeong J. M., Lee D. S., Lee M. C. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy. J Nucl Med 2004; 45(9)1571–1576
   PubMed Web of Science ®Google Scholar
• Haberkorn U., Henze M., Altmann A., Jiang S., Morr I., Mahmut M., Peschke P., Kübler W., Debus J., Eisenhut M. Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells. J Nucl Med 2001; 42(2)317–325
   PubMed Web of Science ®Google Scholar
• Shimura H., Haraguchi A., Miyazaki A., Endo T., Onaya T. Iodide uptake and 131I experimental therapy in transplanted undifferentiated thyroid cancer cells expressing the Na/I symporter gene. Endocrinology 1997; 138(10)4493–4496
   PubMed Web of Science ®Google Scholar